Logo
أحمد محمد صلاح الدين عوضVerified

Ahmad Muhammad Salahuddin Awad

ProfessorAl Ain University, Iraq•College of Pharmacy

Vice dean (college of health & medical technologies) for scientific affairs

Professor of Biochemistry & Molecular Biology

36

Scholar Pubs

25

Scopus Pubs

422

Scholar Citations

233

Scopus Citations

195

WoS Citations

13

h-index

Scopus(25)Google Scholar(36)ORCIDWeb of Science

Personal information

Arabic Name
أحمد محمد صلاح الدين عوض
English Name
Ahmad Muhammad Salahuddin Awad
Date of birth
1981-06-14
The academic title
Professor
Certificate
Doctorate
General Specialization
Pharmacy
Specific Specialization
Clinical chemistry
Email
salahuddin@alayen.edu.iq
Phones
07839451874

Researcher's Scientific Achievements

The number of research papers

Google Scholar
36
Scopus
25
Web of Science
19

Citations number

Google Scholar
422
Scopus
233
Web of Science
195

H-Index

Google Scholar
13
Scopus
10
Web of Science
9

Profile Views

Total Views
388

Education

Certificate

Doctorate
University name:Al-Azhar University
Country:Egypt
Date of obtaining:2011-09-11
Master's Degree
University name:Al-Azhar University
Country:Egypt
Date of obtaining:2007-09-25
Bachelor's Degree
University name:Al-Azhar University
Country:Egypt
Date of obtaining:2004-05-01

Academic titles

Professor
Date of obtaining:2022-11-30
Assistant Professor
Date of obtaining:2017-11-18

Work Positions

Administrative positions

Vice dean (college of health & medical technologies) for scientific affairs
Date:2022-10-01
To Date:Present
Vice dean (college of pharmacy) for scientific affairs
Date:2018-02-01
To Date:2022-10-01

Research & Activities

Research interests

BiochemistryClinical chemistryMolecular Biology

Skills in using scientific software

Microsoft OfficePrism (biostatistics)

Collaborators

Suggested collaborators

Khulood Hayal Oudah
+3 mutual
Ghassan Mohammad Sulaiman
+2 mutual
Salim Albukhaty
+2 mutual
Emad Salaam Abood Abbas Shlakaa
+1 mutual
Uday Muhsin Nayef
+1 mutual
Fahmi Yahya Ahmed Al-Ashwal
+1 mutual

Publications

39

Piceatannol loaded mesenchymal stem cells derived exosomes for cutaneous regenerative treatment of psoriasis-like symptoms in imiquimod-induced mice model: Exosomal hydrogel …

Nanomedicine: Nanotechnology, Biology and Medicine, 103025, 2026
2026

Comparative study between the effects of high doses of rosuvastatin and atorvastatin on ventricular remodeling in patients with ST-segment elevation myocardial infarction

Cardiovascular drugs and therapy 39 (5), 1113-1123, 2025
2025Cited by 8
WoS

Enhanced antitumour efficacy of ferulic acid nanoparticles in combination with doxorubicin–a promising strategy for breast cancer treatment

Contemporary Oncology/Współczesna Onkologia 29 (1), 2025
2025Cited by 1
WoS

Comparison of Postoperative Inflammation, Oxidative Stress, Pain and Cognitive Impairment in Propofol and Sevoflurane: A Randomized Clinical Trial

Bulletin of Pharmaceutical Sciences Assiut University 48 (1), 421-442, 2025
2025

The impact of CBR3 (rs1056892) and ABCC1 (rs45511401) genetic polymorphisms on doxorubicin-induced cardiotoxicity and the potential role of brain natriuretic peptide as an …

Expert Opinion on Drug Metabolism & Toxicology 21 (6), 737-749, 2025
2025Cited by 3

Repurposing of high-dose N-acetylcysteine as anti-inflammatory, antioxidant and neuroprotective  agent  in moderate to severe traumatic brain injury patients: a …

Inflammopharmacology, 1-10, 2025
2025Cited by 9

Neuroprotective effects of punicalagin and/or micronized zeolite clinoptilolite on manganese-induced Parkinson's disease in a rat model: Involvement of multiple pathways

CNS Neuroscience and Therapeutics
2024Cited by 10
WoSORCID

Studying the association between some genetic polymorphisms and Doxorubicin-Induced Cardiotoxicity

Int J Clin Med Res 2 (2), 64-72, 2024
2024Cited by 3

Novel potential drug interactions with bisoprolol in hospitalized acute coronary syndrome patients

Bulletin of Pharmaceutical Sciences Assiut University 47 (1), 395-413, 2024
2024Cited by 1

Impact of CYP2D6* 2A, CYP2D6* 4 and CYP3A5* 3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients

British Journal of Clinical Pharmacology, 2024
2024Cited by 2
WoS

Assessment of the effect of unfractionated heparin administered either by intravenous infusion vs. subcutaneous injection on heparin-binding protein, and plasminogen …

European Review for Medical and Pharmacological Sciences 28 (16), 4199-4213, 2024
2024Cited by 2

Design and Optimization of Sesamol Nanosuspensions to Potentiate the Anti-Tumor Activity of Epirubicin against Ehrlich Solid Carcinoma-Bearing Mice

Pharmaceutics 16 (7), 937, 2024
2024Cited by 6
WoS

Antitumor effect of esculetin on sorafenib -treated human hepatocellular carcinoma cell lines via suppression of VEGF-EGFR/RAS/ERK/NF-κB pathway and modulation of pI3K/ P38 axis crosstalk

Egyptian Journal of Chemistry
2023
WoSORCID

Genetic Polymorphisms and Risk of Cardiovascular Disease

International Journal of Clinical Medical Research 2 (1), 1-10, 2023
2023Cited by 2

Impact of miR-23b and miR-331 Gene Expressions on HCV-Related Hepatocellular Carcinoma in Egyptian Patients

Surgery, Gastroenterology and Oncology 28 (2), 88-95, 2023
2023

Alveolar cleft reconstruction using bone marrow aspirate concentrate and iliac cancellous bone: A 12-month randomized clinical study

Clinical Oral Investigations, 1-9, 2023
2023Cited by 17
WoS

Antitumor effect of esculetin on sorafenib-treated human hepatocellular carcinoma cell lines via suppression of VEGF-EGFR/RAS/ERK/NF-κB pathway and modulation of pI3K/P38 axis …

Egyptian Journal of Chemistry 66 (12), 335-346, 2023
2023Cited by 3

Polymorphic renal transporters and cisplatin’s toxicity in urinary bladder cancer patients: current perspectives and future directions

Medical Oncology 40 (2), 80, 2023
2023Cited by 24
WoS

Evening Primrose Oil Enhances Tamoxifen’s Anticancer Activity against Breast Cancer Cells by Inducing Apoptosis, Inhibiting Angiogenesis, and Arresting the Cell Cycle

Molecules
2022
WoSORCID

Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients

Pharmacogenomics and Personalized Medicine, 663-674, 2022
2022Cited by 6
WoS

Peer Reviews (ORCID)

2

2

Reviews

2

Journals

1times

Molecular Biology Reports

Springer Nature

2021
1times

International Journal of Diabetes in Developing Countries

Springer Nature

2020